LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Cardiac Rhythm Management Devices Market Snapshot

Published July 2024 | 8 Pages | 4 Exhibits | Forecasts Through 2028

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview


This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure.

This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into:

  • Unit volumes from 2023 to 2028
  • Market forecasts from 2023 to 2028
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Abbott

AtaCor Medical

Biotronik

Boston Scientific

Cairdac

Cook Medical

Lepu Medical

LivaNova

Medico

Medtronic

MicroPort Scientific

Osypka

Pacetronix

Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.